Nearly 99% of people with prediabetes and obesity or overweight who took weekly tirzepatide injections remained diabetes-free ...

Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

Both drugs can be used alone or with other diabetes ... injection under your skin). The key difference between Ozempic and Victoza is how often they’re used. Ozempic is injected once per week ...

AstraZeneca announced that the EC green-lighted the new formulation of the once-weekly type-2 diabetes injection, which will be marketed as Bydureon BCise (exenatide 2mg prolonged-release suspension).

Martin UW Photography/Moment via Getty Images A new form of treatment for Type 2 diabetes could eliminate the need for insulin injections ... Presented last week at United European ...

The Danish pharma group reported sales growth of 33% in the first nine months of the year to DKK 166.4 billion ($23.7 billion), driven by a 58% rise in sales of once-weekly diabetes injection ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

receptor agonist that is FDA-approved to improve glycemic control in adult patients with type 2 diabetes mellitus when used ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...